Clinical Trial: Comparing Infectious Morbidity Among Women with Meconium-stained Amniotic Fluid At Term, Between Those Treated with Prophylactic Antibiotics Zinacef Vs. Placebo

U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06849037) titled 'Comparing Infectious Morbidity Among Women with Meconium-stained Amniotic Fluid At Term, Between Those Treated with Prophylactic Antibiotics Zinacef Vs. Placebo' on Feb. 15.

Brief Summary: Our randomized controlled double blind clinical trail aims to compare maternal and neonatal infectious morbidity between women with meconium-stained amniotic fluid treated with zinacef vs. placebo.

Study Start Date: Feb. 25

Study Type: INTERVENTIONAL

Condition: Meconium-stained Amniotic Fluid Chorioamnionitis

Intervention: DRUG: zinacef tretment

prophylactic antibiotic treatment with zinacef

OTHER: Placebo

I.V SALINE 100 CC X3/d

Recruitm...